Search

everythinglearnresearchcommunity

for

Search:↓

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

The best treatment for Frontal Fibrosing Alopecia and Lichen Planopilaris combines oral and topical medications to reduce symptoms and stop hair loss.

Systemic glucocorticosteroids are a primary treatment for various skin conditions but require careful management due to potential side effects and relapses.

Cutaneous lupus erythematosus is a chronic skin disease that can progress to systemic lupus in some cases and requires treatment to prevent recurrences and scarring.

Two patients with lupus had an unusual type of hair loss not typical for the disease but improved with treatment.

The CLASI is a reliable tool for measuring the severity of cutaneous lupus erythematosus.

Dogs with generalized discoid lupus erythematosus have similar symptoms to humans and need continuous treatment.

Lupus can cause hair loss and nail changes, with treatments available for both.

Early and aggressive treatment can significantly regrow hair in discoid lupus erythematosus.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

About 8% of people with systemic lupus erythematosus have chronic scarring alopecia, with certain symptoms and positive antibodies increasing the risk, while immunosuppressants may lower it.

Children with systemic lupus erythematosus have different skin symptoms than adults.

Skin problems are common and early signs of Systemic Lupus Erythematosus, and certain immune system markers are important for diagnosis and treatment.

Damage to hair follicle stem cells causes permanent hair loss and scarring in cutaneous lupus erythematosus.

Chronic cutaneous lupus erythematosus causes scarring, hair loss, and skin discoloration, especially on sun-exposed areas.

Two patients with lupus had an unusual type of hair loss not typical for the disease.

Early recognition and management of connective tissue diseases like lupus are crucial in young patients.

Antigen presenting cells around hair follicles are crucial in SLE-related hair loss.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

Non-scarring hair loss is common in lupus patients and can be diagnosed with specific hair and tissue tests.

Older adults diagnosed with lupus show less severe symptoms but have a lower survival rate, often due to age-related factors.

Undiagnosed lupus can cause severe complications after epidural anesthesia, leading to muscle weakness and potentially death.

Lupus erythematosus can mimic alopecia areata, and trichoscopy is key for accurate diagnosis and better patient outcomes.

Certain skin symptoms can help detect and manage systemic lupus.

Antituberculous drugs improved symptoms in a woman with lupus and myositis.

Experts discussed hair care, genetic hair defects, hair loss treatments, nail surgery, lupus treatments, skin infections, and cosmetic allergies.

The document concludes that early diagnosis and treatment are crucial for managing rare hair loss disorders and that more research is needed to improve treatment strategies.

Children with different rheumatologic diseases have specific skin symptoms that can help with diagnosis.

Some hair loss disorders cause permanent loss due to scarring, and treatments like steroids don't always work well.

The symposium concluded that hair growth involves complex processes, including the hair follicle life cycle, the role of the dermal papilla, hair strength, pigmentation, and the impact of diseases and treatments like minoxidil on hair and skin.